$6.61
1.85% today
Nasdaq, Jul 02, 06:50 pm CET
ISIN
US89455T1097
Symbol
TMCI

Treace Medical Concepts Inc Target price 2024 - Analyst rating & recommendation

Treace Medical Concepts Inc Classifications & Recommendation:

Hold
100%

Treace Medical Concepts Inc Target price

Target price $6.83
Course $6.49
Price potential
Number of estimates 6
6 Analysts have issued a price target Treace Medical Concepts Inc 2025 . The average Treace Medical Concepts Inc target price is $6.83. This is higher than the current share price. The highest price target is , the lowest is .
A rating was issued by 7 analysts: 0 Analysts recommend Treace Medical Concepts Inc to buy, 7 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst estimates: Analysts believe that the Treace Medical Concepts Inc share has an average upside potential 2025 of . Most analysts recommend the Treace Medical Concepts Inc share at Hold.

Sales and margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Forecast
Turnover Million $ 187.12 205.40
31.92% 9.77%
EBITDA margin -24.63% -6.91%
15.70% 71.94%
Net margin -26.81% -27.13%
20.26% 1.20%

7 Analysts have issued a sales forecast Treace Medical Concepts Inc 2024 . The average Treace Medical Concepts Inc sales estimate is

$205m
Unlock
. This is
4.78% higher
Unlock
than the turnover of the last 12 months(TTM). The highest sales forecast is
$208m 5.85%
Unlock
, the lowest is
$204m 4.10%
Unlock
.

This results in the following potential growth figures:

Sales forecast

2023 $187m 31.92%
2024
$205m 9.77%
Unlock
2025
$230m 11.87%
Unlock
2026
$256m 11.53%
Unlock
2027
$311m 21.34%
Unlock
2028
$358m 15.02%
Unlock

6 Analysts have issued an Treace Medical Concepts Inc EBITDA forecast 2024. The average Treace Medical Concepts Inc EBITDA estimate is

$-14.2m
Unlock
. This is
71.40% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-10.1m 79.75%
Unlock
, the lowest is
$-17.9m 63.95%
Unlock
.

This results in the following potential growth figures and future EBITDA margins:

EBITDA forecast

2023 $-46.1m 52.63%
2024
$-14.2m 69.18%
Unlock
2025
$-6.5m 54.47%
Unlock
2026
$-592k 90.85%
Unlock
2027
$15.1m 2,651.97%
Unlock
2028
$33.7m 123.18%
Unlock

EBITDA margin

2023 -24.63% 15.70%
2024
-6.91% 71.94%
Unlock
2025
-2.81% 59.33%
Unlock
2026
-0.23% 91.81%
Unlock
2027
4.86% 2,213.04%
Unlock
2028
9.42% 93.83%
Unlock

5 Treace Medical Concepts Inc Analysts have issued a net profit forecast 2024. The average Treace Medical Concepts Inc net profit estimate is

$-55.7m
Unlock
. This is
1.09% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-50.8m 7.87%
Unlock
, the lowest is
$-59.4m 7.68%
Unlock
.

This results in the following potential growth figures and future net margins:

Net profit forecast

2023 $-50.2m 5.19%
2024
$-55.7m 11.08%
Unlock
2025
$-53.3m 4.43%
Unlock
2026
$-48.7m 8.56%
Unlock
2027
$-29.1m 40.21%
Unlock
2028
$-15.5m 46.82%
Unlock

Net margin

2023 -26.81% 20.26%
2024
-27.13% 1.20%
Unlock
2025
-23.17% 14.60%
Unlock
2026
-19.00% 18.00%
Unlock
2027
-9.36% 50.74%
Unlock
2028
-4.33% 53.74%
Unlock

Earnings per share, P/E ratio and EV/sales forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Forecast
Earnings per share $ -0.81 -0.90
5.19% 11.11%
P/E ratio negative
EV/Sales 1.77

5 Analysts have issued a Treace Medical Concepts Inc forecast for earnings per share. The average Treace Medical Concepts Inc <a href=/blog/eps>EPS is

$-0.90
Unlock
. This is
1.12% lower
Unlock
than earnings per share in the financial year 2023. The highest <a href=/blog/eps>EPS forecast is
$-0.82 7.87%
Unlock
, the lowest is
$-0.96 7.87%
Unlock
.

This results in the following potential growth figures and future valuations:

Earnings per share

2023 $-0.81 5.19%
2024
$-0.90 11.11%
Unlock
2025
$-0.86 4.44%
Unlock
2026
$-0.79 8.14%
Unlock
2027
$-0.47 40.51%
Unlock
2028
$-0.25 46.81%
Unlock

P/E ratio

Current -7.30 70.48%
2024
-7.21 1.23%
Unlock
2025
-7.55 4.72%
Unlock
2026
-8.25 9.27%
Unlock
2027
-13.81 67.39%
Unlock
2028
-25.96 87.98%
Unlock

Based on analysts' sales estimates for 2024, the Treace Medical Concepts Inc share is valued at an <a href=/blog/ev-sales-einfach-erklaert>EV/Sales of

and an <a href=/blog/kurs-umsatz-verhaeltnis-kuv-einfach-erklaert>P/S ratio of .

This results in the following potential growth figures and future valuations:

EV/Sales

Current 1.85 80.46%
2024
1.77 4.59%
Unlock
2025
1.58 10.62%
Unlock
2026
1.41 10.34%
Unlock
2027
1.17 17.59%
Unlock
2028
1.01 13.06%
Unlock

P/S ratio

Current 2.05 79.72%
2024
1.96 4.56%
Unlock
2025
1.75 10.61%
Unlock
2026
1.57 10.34%
Unlock
2027
1.29 17.59%
Unlock
2028
1.13 13.06%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today